Patients with hereditary angioedema who switched from other drugs to donidalorsen for long-term prophylaxis experienced fewer attacks and improved disease control, according to a poster presented here ...

Hereditary angioedema (HAE) is a rare condition that causes fluid to build up throughout your body, triggering sudden and repeated serious swelling. This is the most common type and happens ...

As KalVista Pharmaceuticals awaits an FDA decision on its hereditary angioedema (HAE) treatment sebetralstat, the company has ...

Swelling in hereditary angioedema (HAE) can arise from exposure to triggers like stress, infection, and injury. For some people, dietary triggers can also be a cause of HAE swelling episodes.

The following is a summary of “Comorbidities in Canadian patients with hereditary angioedema: a quantitative survey study,” published in the March 2025 issue of Allergy, Asthma & Clinical Immunology ...

BHUBANESWAR : Hereditary angioedema is a rare genetic disorder which can affect several members of the family, said experts at a CME organised at SCB Medical College and Hospital at Cuttack.

Cold compresses aren’t a first-line therapy for hereditary angioedema (HAE), but they may provide relief from swelling-related discomfort for some people. HAE is a rare genetic disorder that ...

The following is a summary of “Origin of YouTube videos on hereditary angioedema matters,” published in the March 2025 issue ...

US-based biopharmaceutical company KalVista Pharmaceuticals has finished enrolling subjects in its KONFIDENT-KID trial of sebetralstat, an oral plasma kallikrein inhibitor designed to treat hereditary ...

Pharmaceuticals announced that its wholly-owned subsidiary, KalVista Pharmaceuticals, Ltd., has licensed commercialization ...

oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema (HAE) and acquired angioedema due to C1 ...

1.9% of hereditary angioedema attacks involved the larynx, which could be fatal. Patients took sebetralstat 11.5 minutes after these attacks began. 96% of patients saw relief after one dose of ...